نتایج جستجو برای: eptifibatide acetate

تعداد نتایج: 50475  

Journal: :Current Controlled Trials in Cardiovascular Medicine 2000
Jassim Al Suwaidi Amar M Salam

New strategies for profound inhibition of platelet activity at the injured coronary plaque focus on blockade of the platelet surface membrane glycoprotein IIb/IIIa receptor, which binds circulating fibrinogen or von Willebrand factor and crosslinks platelets as the final common pathway to platelet aggregation. Intravenous agents directed against this receptor include the chimeric monoclonal ant...

2014
Melissa Li Nathan A. Hotaling David N. Ku Craig R. Forest

The mainstay of treatment for thrombosis, the formation of occlusive platelet aggregates that often lead to heart attack and stroke, is antiplatelet therapy. Antiplatelet therapy dosing and resistance are poorly understood, leading to potential incorrect and ineffective dosing. Shear rate is also suspected to play a major role in thrombosis, but instrumentation to measure its influence has been...

Journal: :Journal of the American College of Cardiology 2004
Shinya Goto Noriko Tamura Hideyuki Ishida

OBJECTIVES We examined the lytic effects of anti-glycoprotein (GP) IIb/IIIa agents on platelet thrombi formed on the collagen surface under blood flow conditions. BACKGROUND Anti-GP IIb/IIIa agents may influence platelet thrombi already formed. METHODS Blood samples were anticoagulated either by the specific antithrombin Argatroban (100 microM) or by unfractionated heparin (0.1 U/ml). After...

Journal: :Current Controlled Trials in Cardiovascular Medicine 2001
Kenneth W Mahaffey Robert A Harrington Martijn Akkerhuis Neal S Kleiman Lisa G Berdan Brian S Crenshaw Barbara E Tardiff Christopher B Granger Ingrid DeJong Manju Bhapkar Petr Widimsky Ramón Corbalon Kerry L Lee Jaap W Deckers Maarten L Simoons Eric J Topol Robert M Califf

BACKGROUND: Clinical events committees (CEC) are used routinely to adjudicate suspected end-points in cardiovascular trials, but little information has been published about the various processes used. We reviewed results of the CEC process used to identify and adjudicate suspected end-point (post-enrolment) myocardial infarction (MI) in the large Platelet Glycoprotein IIb/IIIa in Unstable Angin...

Journal: :Journal of cardiovascular pharmacology 2001
G Amoroso A J van Boven D J van Veldhuisen R A Tio C P Baljé-Volkers A S Petronio W van Oeveren

Platelet deposition and aggregation are the major determinants of acute thrombosis in coronary stents. We aimed to compare the antiplatelet efficacy of different treatments--glycoprotein (Gp) IIb/IIIa inhibitors and conventional antiaggregants--in an experimental model for stenting. Blood samples were obtained from patients with coronary artery disease (n = 15) and healthy volunteers (n = 8) an...

Journal: :acta medica iranica 0
gh. karimi a. khoshbaten. a.r. dehpour--. m. abdollahi m. sharifzadeh

effects of 28 days lead acetate (ioc, 500, 1000 ppm) treatment on hypertension ami relationship between blood lead levels and hypertension in male. spraguc-dawley rats were studied. results of this study showed tlxat lead acetate treatment did run decrease, body wcight or water consumption, except for lead acetate (1000 ppm) and sodium acetate (500 ppm) which increased fluid consumption when co...

Journal: :European heart journal 2000
K M Akkerhuis J W Deckers E Boersma R A Harrington J Stepinska K W Mahaffey R G Wilcox A M Lincoff M Keltai E J Topol R M Califf M L Simoons

AIMS Variations in outcome of patients from different geographic regions have been observed in many large international trials. We analysed the factors that might contribute to the geographic variations in patient outcome and treatment effect as observed in the PURSUIT trial. METHODS In PURSUIT, 9461 patients with acute coronary syndromes without persistent ST-elevation were randomized to the...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید